Pulmonx
LUNG
107 hedge funds and large institutions have $514M invested in Pulmonx in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 20 closing their positions.
59% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 29
1.44% more ownership
Funds ownership: 93.76% → 95.21% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
2% less funds holding
Funds holding: 109 → 107 (-2)
40% less capital invested
Capital invested by funds: $861M → $514M (-$347M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$39.1M |
| 2 |
JG
Jefferies Group
New York
|
+$18.4M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$15.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$53.8M |
| 2 |
MGM
Miura Global Management
New York
|
-$14.8M |
| 3 |
PA
Perceptive Advisors
New York
|
-$13.3M |
| 4 |
BlackRock
New York
|
-$6.79M |
| 5 |
DM
Deerfield Management
New York
|
-$4.73M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$185 | +9 | New |
|
LUNG Hedge Fund Activity: Q2 2022 in Review
107 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q2 2022, worth a combined $514M — down 40% from $861M a quarter earlier.
Fund positioning in LUNG was balanced in Q2 2022: 20 funds opened new positions, 20 closed out, 46 added to existing stakes and 29 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $39.1M. The largest seller was Capital World Investors, cutting an estimated $53.8M.
- 107 institutional investors held Pulmonx (LUNG) as of Q2 2022, down from 109 in Q1 2022.
- Funds reported $514M of Pulmonx stock for Q2 2022, down 40% quarter-over-quarter.
- 20 funds opened new Pulmonx positions in Q2 2022 and 20 closed out, a net change of 0 holders.
- The largest Pulmonx buyer in Q2 2022 was Morgan Stanley, an estimated $39.1M added.
- The largest Pulmonx seller in Q2 2022 was Capital World Investors, an estimated $53.8M sold.
Based on aggregated 13F filings for Q2 2022.